{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:59:45Z","timestamp":1791824385466,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.autrev.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T02:36:25Z","timestamp":1499654185000},"page":"984-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["Effects of Interleukin 17 on the cardiovascular system"],"prefix":"10.1016","volume":"16","author":[{"given":"Marie","family":"Robert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2017.07.009_bb0005","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.009_bb0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fimmu.2015.00591","article-title":"High-risk cardiovascular patients: clinical features, comorbidities, and interconnecting mechanisms","volume":"6","author":"Schuett","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0030","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.009_bb0045","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","article-title":"Cardiovascular disease in autoimmune rheumatic diseases","volume":"12","author":"Hollan","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","article-title":"Different effects of biological drugs in rheumatoid arthritis","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2017.07.009_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","article-title":"Inflammation: a pivotal link between autoimmune diseases and atherosclerosis","volume":"5","author":"Abou-Raya","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2010.10.003","article-title":"Interleukin 17 in vascular inflammation","volume":"21","author":"von Vietinghoff","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0085","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0095","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2017.07.009_bb0100","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4049\/jimmunol.162.3.1246","article-title":"IL-17 is produced by some proinflammatory Th1\/Th0 cells but not by Th2 cells","volume":"162","author":"Aarvak","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0105","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.009_bb0125","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2017.07.009_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.07.009_bb0145","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.07.009_bb0155","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.07.009_bb0165","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.2010.143768","article-title":"Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes","volume":"70","author":"Hot","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jcp.10333","article-title":"Endothelial cell functions","volume":"196","author":"Michiels","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0175","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1159\/000430197","article-title":"Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment","volume":"36","author":"Yuan","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.autrev.2017.07.009_bb0180","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0190","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0195","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2011.04.080","article-title":"IL-17A increases ADP-induced platelet aggregation","volume":"408","author":"Maione","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.07.009_bb0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2011.07.003","article-title":"IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome","volume":"141","author":"Zhu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0205","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","article-title":"Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes","volume":"182","author":"Zrioual","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cyto.2016.09.019","article-title":"T-cell clones from Th1, Th17 or Th1\/17 lineages and their signature cytokines have different capacity to activate endothelial cells or synoviocytes","volume":"88","author":"Lavocat","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2017.07.009_bb0215","doi-asserted-by":"crossref","first-page":"817375","DOI":"10.1155\/2010\/817375","article-title":"IL-17B can impact on endothelial cellular traits linked to tumour angiogenesis","volume":"2010","author":"Sanders","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0220","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.169.2.642","article-title":"Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis","volume":"169","author":"Starnes","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0225","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.1014241108","article-title":"T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma","volume":"108","author":"Corrigan","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2017.07.009_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF03085963","article-title":"Regulation and characteristics of vascular smooth muscle cell phenotypic diversity","volume":"15","author":"Rensen","year":"2007","journal-title":"Neth Hear J"},{"key":"10.1016\/j.autrev.2017.07.009_bb0235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0240","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.07.009_bb0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000317400","article-title":"Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species","volume":"48","author":"Pietrowski","year":"2011","journal-title":"J Vasc Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0250","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/CIRCRESAHA.108.175976","article-title":"Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration","volume":"102","author":"Clarke","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006133","article-title":"Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway","volume":"5","author":"Gistera","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0260","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/ATVBAHA.110.221549","article-title":"The adventitia: a dynamic interface containing resident progenitor cells","volume":"31","author":"Majesky","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0265","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bcp.2009.03.008","article-title":"Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes","volume":"77","author":"Shin","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0270","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.4049\/jimmunol.1001269","article-title":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity","volume":"185","author":"Zuniga","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0275","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCRESAHA.114.302157","article-title":"Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase","volume":"114","author":"Wu","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0280","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.biocel.2005.04.011","article-title":"Cardiomyocytes structure, function and associated pathologies","volume":"37","author":"Woodcock","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0285","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0290","first-page":"2784","article-title":"Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway","volume":"2016","author":"Su","year":"1863","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2017.07.009_bb0295","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","article-title":"Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration","volume":"59","author":"Liao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00109-014-1176-8","article-title":"IL-17A promotes ventricular remodeling after myocardial infarction","volume":"92","author":"Zhou","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2017.07.009_bb0305","doi-asserted-by":"crossref","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","article-title":"IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-beta, NF-kappaB, and AP-1 activation","volume":"293","author":"Cortez","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0310","doi-asserted-by":"crossref","first-page":"H2078","DOI":"10.1152\/ajpheart.01363.2007","article-title":"Resveratrol inhibits high glucose-induced PI3K\/Akt\/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts","volume":"294","author":"Venkatachalam","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0315","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004408","article-title":"Deleterious effect of the IL-23\/IL-17A axis and gammadeltaT cells on left ventricular remodeling after myocardial infarction","volume":"1","author":"Yan","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.autrev.2017.07.009_bb0320","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1084\/jem.20132126","article-title":"Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy","volume":"211","author":"Wu","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0325","doi-asserted-by":"crossref","first-page":"C1799","DOI":"10.1152\/ajpcell.00166.2006","article-title":"Cardiac fibroblasts influence cardiomyocyte phenotype in vitro","volume":"292","author":"LaFramboise","year":"2007","journal-title":"Am J Phys Cell Phys"},{"key":"10.1016\/j.autrev.2017.07.009_bb0330","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","article-title":"Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice","volume":"388","author":"van Es","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2017.07.009_bb0340","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.07.009_bb0345","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0350","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0355","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0360","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0365","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH12-06-0425","article-title":"Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction","volume":"109","author":"de Boer","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2017.07.009_bb0370","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/eurheartj\/ehs263","article-title":"Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction","volume":"34","author":"Simon","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2017.07.009_bb0375","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/ATVBAHA.116.307892","article-title":"Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory Interleukin-17A+ T cells to the aorta","volume":"36","author":"Butcher","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117255","article-title":"IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice","volume":"10","author":"Mantani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.07.009_bb0385","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1161\/CIRCULATIONAHA.111.083451","article-title":"Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment","volume":"126","author":"Sharma","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2017.07.009_bb0390","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/ATVBAHA.112.301049","article-title":"Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL\/6 mice","volume":"33","author":"Ju","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0395","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1161\/ATVBAHA.114.304435","article-title":"Inhibiting the Th17\/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm","volume":"34","author":"Wei","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","article-title":"Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency","volume":"5","author":"Chandesris","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.autrev.2017.07.009_bb0405","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/ATVBAHA.112.300516","article-title":"Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice\u2013brief report","volume":"33","author":"Romain","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0410","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2011.08.849","article-title":"Enhanced IL-17 signalling following myocardial ischaemia\/reperfusion injury","volume":"163","author":"Barry","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0415","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","article-title":"Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease","volume":"17","author":"Hashmi","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0425","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","article-title":"Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury","volume":"15","author":"Shichita","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0430","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2012-02-412726","article-title":"Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke","volume":"120","author":"Gelderblom","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.07.009_bb0435","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","article-title":"Expression of interleukin-17 in ischemic brain tissue","volume":"62","author":"Li","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0440","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.autrev.2017.07.009_bb0445","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.autrev.2017.07.009_bb0450","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0455","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0460","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2017.07.009_bb0465","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/thx.2007.094540","article-title":"Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung","volume":"64","author":"Imamura","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2017.07.009_bb0470","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.180.10.6988","article-title":"Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes","volume":"180","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0475","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/annrheumdis-2012-201887","article-title":"Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells","volume":"72","author":"Hot","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0480","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2010.09.004","article-title":"Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF","volume":"362","author":"DeForge","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2017.07.009_bb0485","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/annrheumdis-2016-209149","article-title":"Negative association between autoantibodies against IL-17, IL-17\/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis","volume":"75","author":"Ndongo-Thiam","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0490","first-page":"2285","article-title":"Th1\/Th17 cytokine profiles in patients with reactive arthritis\/undifferentiated spondyloarthropathy","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2017.07.009_bb0495","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/annrheumdis-2014-207110","article-title":"A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis","volume":"74","author":"Ndongo-Thiam","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.07.009_bb0500","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2017.07.009_bb0505","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies comparing Brodalumab with Ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2017.07.009_bb0510","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","article-title":"Targeting interleukin-1 in heart disease","volume":"128","author":"Van Tassell","year":"2013","journal-title":"Circulation"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:07:04Z","timestamp":1692860824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1568997217301805"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Interleukin 17 on the cardiovascular system","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}